Latest Commercialisation News

Argosy Minerals has executed a spot sales contract for 60 tonnes of high-purity lithium carbonate from its Rincon project, marking a significant step in its lithium market engagement.

Andromeda Metals has launched a $5 million capital raising via a Placement, accompanied by Placement and Broker Options, to advance its flagship Great White Project and High Purity Alumina development.

Microba Life Sciences has announced a $14.5 million capital raising, including a $2 million fully underwritten Securities Purchase Plan (SPP) and a $12.5 million Placement, aimed at fast-tracking commercialisation of its microbiome diagnostic tests in Australia and the UK.

Atomo Diagnostics has successfully closed a Share Purchase Plan and secured shareholder approval for a Tranche 2 Placement, raising a combined $1.53 million to support its ongoing operations.

Condor Energy has launched a comprehensive market and commercialisation study for its 1 trillion cubic feet Piedra Redonda gas discovery offshore Peru, aiming to chart a clear path toward development and partnerships.

Adherium Limited has announced a partially underwritten entitlement offer aiming to raise approximately A$4.5 million through the issuance of new shares and options at a significant discount. The capital raise is designed to accelerate patient onboarding and product development for its respiratory monitoring technology.

Percheron Therapeutics has licensed HMBD-002, a promising immuno-oncology monoclonal antibody targeting VISTA, from Hummingbird Bioscience, marking a strategic pivot after recent setbacks. The company plans to initiate phase II trials in 2026, aiming to advance this novel cancer therapy toward commercialisation.

Neometals’ joint venture Reed Advanced Materials has signed a non-binding MoU with Rio Tinto to collaborate on advancing the ELi Process, a lithium hydroxide production technology promising significant cost and environmental benefits.

Neuren Pharmaceuticals has been granted a US patent for NNZ-2591 to treat Pitt Hopkins syndrome, bolstered by promising Phase 2 clinical trial results and FDA orphan drug status.

MTM Critical Metals has raised A$50 million through a well-supported institutional placement to accelerate the rollout of its proprietary Flash Joule Heating technology in the U.S. This capital injection marks a pivotal step in MTM’s transformation into a U.S.-focused clean technology company.

ABx Group’s ALCORE subsidiary updates on the status of its $7.58 million Federal Government grant, revealing repayment negotiations while advancing its innovative pilot plant in Tasmania.

Parkway Corporate Limited has secured over $13.5 million in water infrastructure contracts, including a major $12.85 million deal with a leading engineering firm, while advancing its innovative brine management technology and extending its loan facility to support expansion.